Literature DB >> 3160540

Animal studies of toxic shock syndrome.

F Quimby, H T Nguyen.   

Abstract

Toxic shock syndrome (TSS) was first described in 1978 and since that year over 2990 cases have been reported to the Communicable Disease Center. The estimated case-fatality rate is 5.6%. The disease is characterized by fever, hypotension, rash, desquamation, and involvement of at least three other organ systems. Approximately 85% of the cases are menstrually related and tampon use has been identified as a risk factor. The remaining 15% of the cases occur in both sexes and are not specifically related to age or geographic location. In all cases where sought there is evidence for infection by Staphylococcus aureus. Nearly all S. aureus isolates are phage type 52/29 and elaborate a unique exotoxin (toxic shock toxin). This review explores both the successful and unsuccessful attempts to induce toxic shock or a TSS-like syndrome in animals other than man. The review identifies the baboon as an animal model of TSS and discusses the clinical and pathologic sequellae, in this species, after exposure to purified toxic shock toxin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3160540     DOI: 10.3109/10408418509104424

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  14 in total

Review 1.  Superantigens related to Kawasaki syndrome.

Authors:  D Y Leung
Journal:  Springer Semin Immunopathol       Date:  1996

2.  Production of gamma-hemolysin and lack of production of alpha-hemolysin by Staphylococcus aureus strains associated with toxic shock syndrome.

Authors:  M Clyne; J De Azavedo; E Carlson; J Arbuthnott
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

3.  Nucleotide sequence of the type A staphylococcal enterotoxin gene.

Authors:  M J Betley; J J Mekalanos
Journal:  J Bacteriol       Date:  1988-01       Impact factor: 3.490

4.  Synergistic induction of interleukin-1 by endotoxin and toxic shock syndrome toxin-1 using rat macrophages.

Authors:  D H Beezhold; G K Best; P F Bonventre; M Thompson
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

5.  Investigation by syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.

Authors:  A C Lee; B A Crass; M S Bergdoll
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

Review 6.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

7.  Association of toxic shock toxin-1 determinant with a heterologous insertion at multiple loci in the Staphylococcus aureus chromosome.

Authors:  M C Chu; B N Kreiswirth; P A Pattee; R P Novick; M E Melish; J F James
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

8.  Variable effect of toxic shock toxins from different sources on neutrophil function in vitro.

Authors:  E M Berger; G A Shibao; S N Brown; J E Repine
Journal:  Inflammation       Date:  1988-10       Impact factor: 4.092

9.  Toxin involvement in methicillin-resistant Staphylococcus aureus enteritis in gastroenterological surgery.

Authors:  Y Takesue; T Yokoyama; T Kodama; T Santou; A Nakamitsu; Y Murakami; Y Imamura; K Miyamoto; M Okita; H Tsumura
Journal:  Gastroenterol Jpn       Date:  1991-12

10.  Toxic shock syndrome toxin 1 enhances synthesis of endotoxin-induced tumor necrosis factor in mice.

Authors:  E Henne; W H Campbell; E Carlson
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.